Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Recombinant porcine factor VIII (B domain deleted)

EU orphan designation number: EU/3/10/784
Active ingredient: Recombinant porcine factor VIII (B domain deleted)
Indication: Treatment of haemophilia A
Sponsor: Baxalta Innovations GmbH
Industriestraße 67, 1221 Wien, Österreich

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/09/2010 Orphan designation EMA/OD/043/10 (2010)6651 of 20/09/2010
19/07/2013 Transfer of orphan designation EMA/OD/043/10/T/01 (2013)4742 of 17/07/2013
28/05/2015 Change of name and/or address of sponsor
03/09/2015 Other procedure
23/10/2015 Removal of orphan designation from Community Register